Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

43.00
Delayed Data
As of Dec 02
 +1.67 / +4.04%
Today’s Change
19.59
Today|||52-Week Range
63.71
-30.57%
Year-to-Date

Today’s Trading

Previous close41.33
Today’s open41.18
Day’s range40.67 - 43.97
Volume1,793,737
Average volume (3 months)2,463,903
Market cap$5.0B
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-51.58%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book24.77

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+0.14+0.91%
UTHRUnited Therapeutics ...-0.47-0.37%
MNKMallinckrodt Plc+0.51+0.96%
OPKOPKO Health Inc+0.09+0.87%
Data as of 4:02pm ET, 12/02/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts


Search for Jobs